Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Other Working Capital Changes (2016 - 2025)

Marimed (MRMD) has disclosed Other Working Capital Changes for 12 consecutive years, with -$1.3 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 172.44% to -$1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Dec 2025, down 17.21% year-over-year, with the annual reading at -$1.0 million for FY2025, 17.21% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$1.3 million at Marimed, down from $321000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $3.2 million in Q4 2022, with the low at -$3.5 million in Q3 2023.
  • Average Other Working Capital Changes over 5 years is -$16550.0, with a median of $211000.0 recorded in 2021.
  • Peak annual rise in Other Working Capital Changes hit 1306.38% in 2021, while the deepest fall reached 19366.13% in 2021.
  • Over 5 years, Other Working Capital Changes stood at -$773000.0 in 2021, then soared by 519.92% to $3.2 million in 2022, then plummeted by 175.79% to -$2.5 million in 2023, then skyrocketed by 80.53% to -$479000.0 in 2024, then plummeted by 172.44% to -$1.3 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$1.3 million, $321000.0, and $189000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.